Reliable Data
Are you measuring at the right moment?
THE PROBLEM: WHEN IS THE RIGHT MOMENT TO MEASURE?
An estimated 1.4 billion adults aged 30-79 years worldwide have hypertension, with 44% unaware of their condition (WHO).
Blood Pressure is intended to be measured when a person is in a relaxed physiological state. The World Health Organization (WHO) Guidelines mandate:
- Relax & sit with straight back for at least 5 minutes.
- No talking while relaxing before measurement.
- Repeated measurements and average the readings.
All in a busy home or 10-15 minute GP consultation?
OUR SOLUTION: ASSESS BEFORE YOU MEASURE
By determining the physiological state of a patient, we can drastically optimize the clinical workflow while improving:
- Measurement Reliability
- Patient Outcomes
- Clinical Decisions
Our patent-pending technology (PCT) unlocks huge market potential by assessing physiological state before measurement. Using advanced algorithms and bio-signals (ECG/PPG), our platform identifies the perfect moment to take a reading, delivering a frictionless, world-class user experience.
Regulatory & Reimbursement
Regulatory
Our focus is on FDA approval first then CE Certification (class IIa).
510(k) under 21 CFR 870.1130 (class II, product code DXN)
- Noninvasive blood pressure measurement system.
Reimbursement
Clinics can bill CPT 99473/99474 (self-measured BP setup and monthly analysis) or 99453-99458
The BP diagnostic assessment supports MIPS Quality 236.
THE OPPORTUNITY
Wavescope’s ambition doesn’t stop at blood pressure readiness. It moves into primary healthcare and AI driven decision support.
PHASE 1 (2 - 3 yrs)
BP Measurement Readiness IP Platform
PHASE 2 (3 - 5 yrs)
Pre Clinic Vital Signs Assessment (PCVSA) in Primary Healthcare[1]
PHASE 3 (4 - 6 yrs)
Enables Data Business & Decision Support System
[1] Broughan J, McMahon S, Bailey D, Grant J, McCombe G, Sheil J, Cullen W. Assessing the feasibility and acceptability of implementing a pilot pre-clinic vital signs assessment in primary care. JMIR Medical Informatics.
Partners & Consortium
AINM DTIF Consortium & Backers
Supported by €1 million in non-dilutive matched funding from the Irish Government via the Disruptive Technologies Innovation Fund.
Team
our Team
Alan Gormley
Chief Commercial OfficerInnovator, influencer, strategist, expert in global standards and product commercialization.
Sean McMahon
CEO & Co-FounderInnovative engineer developing high precision devices. Led medical neural network AI research.
Dr Jennifer Grant
Chief Medical OfficerQualified Doctor & Pharmacist. Clinical Lead at Beacon Health Check. Over 20 years experience.
James Sheil
Head of Design20 years experience in Digital Product, Human Factors, Usability, and UX Design.
Steen Gordon
Commercial AdvisorExpert in strategic growth, partnerships, and commercial development.
Whats New
Latest News
Todays data is tomorrows AI.
6 December 2025 In wavescope, we believe in accurate, precise and 𝐫𝐞𝐥𝐢𝐚𝐛𝐥𝐞 blood pressure measurements. Our research led us to file an international patent application through the PCT system.Then we designed and fabricated our own blood pressure device to prove the concept 🎉
With special thanks to Paul Morrow Technological University of the Shannon and Microchip Technology Inc.
Contact
Contact Us